CTOs on the Move

Relievant Medsystems

www.relievant.com

 
Relievant Medsystems, Inc., a privately held medical device company pioneering the INTRACEPT therapy of nerve ablation within vertebral bodies for the treatment of chronic low back pain (CLBP). The INTRACEPT Intraosseous Nerve Ablation System is a patent-protected, minimally invasive, implant-free therapy that utilizes radiofrequency energy delivered into the vertebral body of the spine to ablate the Basivertebral Nerve (BVN). This nerve, characterized in peer-reviewed literature reporting studies of pain signal transmission and in preclinical and clinical evaluations, is a significant contributor in the transduction of pain arising from degeneration of the vertebral bodies associated with CLBP. The INTRACEPT Intraosseous ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.relievant.com
  • 2688 Middlefield Rd Ste A
    Redwood City, CA USA 94063
  • Phone: 650.368.1000

Executives

Name Title Contact Details

Funding

Relievant Medsystems raised $36M on 10/11/2016
Relievant Medsystems raised $58M on 06/26/2018
Relievant Medsystems raised $70M on 10/29/2020

Similar Companies

SOC Telemed

SOC Telemed (SOC) is the largest national provider of telemedicine technology and solutions to hospitals, health systems, post-acute providers, physician networks, value-based care organizations, and health plans. Built on proven and scalable infrastructure as an enterprise-wide solution, SOC`s technology platform, Telemed IQ, rapidly deploys and seamlessly optimizes telemedicine programs across the continuum of care. SOC provides a supportive and dedicated partner presence, virtually delivering patient care through teleNeurology, telePsychiatry and teleICU as well as enabling healthcare organizations to build sustainable telemedicine programs in any clinical specialty. SOC enables organizations to enrich their care models and touch more lives by supplying healthcare teams with industry-leading solutions that drive improved clinical care, patient outcomes, and organizational health. The company was the first provider of acute clinical telemedicine services to earn The Joint Commission`s Gold Seal of Approval and has maintained that accreditation every year since inception.

OncoCell MDx

OncoCellMDx is a privately held company dedicated to the development and commercialization of novel diagnostic tests utilizing proprietary technologies created at Harvard Medical School. In particular, we have developed a noninvasive blood-based immunogenomic assays that will aid the physician to better understand the underlying pathology. The first product is for assessing the severity of prostate cancer. Other oncology indications as well as non-oncology indications are part of our pipeline. The assay is based on examining specific transcription levels between phagocytic and non-phagocytic cells. This proprietary technology and algorithm has allowed us to not only detect disease but to also, and more importantly, guide the physician as to the grade and aggressiveness of the disease. Our mission is to provide clinicians with quantifiable results that allows professionals to make timely and much more directed medical decisions.

Amida Care, Inc.

Amida Care, Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in New York, NY. To find more information about Amida Care, Inc., please visit www.amidacareny.org

Akeso Care Management

Akeso Care Management is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Adelaide Environmental Health Associates

Adelaide Environmental Health Associates is a Brewster, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.